Plasmids and transfection.

WM Wenjuan Ma
YW Yanling Wang
RZ Rongxin Zhang
FY Fan Yang
DZ Duo Zhang
MH Menggui Huang
LZ Lin Zhang
JD Jay F. Dorsey
ZB Zev A. Binder
DO Donald M. O’Rourke
JF Joseph A. Fraietta
YG Yanqing Gong
YF Yi Fan
ask Ask a question
Favorite

Full-length wild-type PAK4 DNA was amplified by PCR using a human complementary DNA library and primers including 5′ AATTGGATCCATGTTTGGGAAGAGGAAGAAGC-3′ and 5′- AATTGCGGCCGCTTACTTGTCATCGTCGTCCTTGTAGTCTCTGGTGCGGTTCTGGCGCA-3′, and subcloned into pcDNA3 vector at the BamHI/NotI sites. PAK4K350M DNA was generated by site-directed mutagenesis (Q5 Site-Directed Mutagenesis Kit; New England Biolabs) using wild-type PAK4 as a template and primers including 5′-GGTGGCCGTCATGATGATGGACCTGCG-3′ and 5′- AGCTTGCCCGAGCTGCGC-3′. Plasmid construction was verified by restriction digestion and DNA sequencing. Cells were transfected with plasmids using Lipofectamine (Invitrogen; L3000001) in serum-free Opti-MEM medium (Gibco; 31985-070).

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A